A new multi-omics metric called PAAG (Personalized-context-Aware Age Gap) outperforms conventional aging clocks by accounting for stratified aging patterns across different life stages, demonstrating superior predictive accuracy for chronic disease risk and clinical outcomes. The underlying model, AOE-Net, uses age-order enhanced learning on healthy population data to distinguish biological aging signals from technical noise in omics data.
Key Points
- PAAG predicts cancer survival, atherosclerosis, and bone density better than current aging clocks
- Immune-response pathways emerge as shared molecular drivers of accelerated aging and disease
- Context-aware approach eliminates age-stage biases that distort traditional age gap interpretations
Longevity Analysis
Accurate measurement of biological aging acceleration is foundational to any intervention strategy. Current aging clocks treat chronological age as a uniform measure, missing the reality that aging patterns diverge significantly across life stages—a critical interpretive error that leads to misidentification of actual risk. PAAG's ability to decode these stratified patterns with precision creates a more reliable signal for identifying individuals at elevated disease risk before clinical manifestation. The identification of immune-response dysfunction as a mechanistic axis linking accelerated aging to multiple disease states suggests that strategies targeting immune homeostasis may address a root driver affecting multiple systems simultaneously, rather than treating disease phenotypes in isolation.
Original published by Wiley Aging Cell, by Feng‐Ao Wang, Tao Zeng, Chunchun Yuan, Hongyu Wang, Yule Yu, Enjin Deng, Yao Wang, Jiangxun Ji, Jiarui Cui, Dezhi Tang, Ruikun He, Yongjun Wang, Yixue Li .